Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Mouth Neoplasms
Diseases [C] » Stomatognathic Diseases [C07] » Mouth Diseases » Mouth Neoplasms
Hierarchy View
Subtype Terms (6)
Leukoplakia, Oral
11 drugs (9 approved, 2 experimental)
Lip Neoplasms
4 approved drugs
Salivary Gland Neoplasms
93 drugs (55 approved, 38 experimental)
Tongue Neoplasms
53 drugs (30 approved, 23 experimental)
Phase 4 Indicated Drugs (5)
Phase 2 Indicated Drugs (20)
Other Experimental Indicated Drugs (8)
Organization Involved with Phase 4 Indications (3)
Organization Involved with Phase 3 Indications (25)
Organization Involved with Phase 2 Indications (40)
Instituto do Cancer do Estado de São Paulo
Jawaharlal Nehru Medical College
Medical University of South Carolina
National Comprehensive Cancer Network
National Institute of Dental and Craniofacial Research (NIDCR)
Organization Involved with Phase 1 Indications (18)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
